Angers University Hospital
Angers, 49933, France
NCT Number: NCT01315717
The purpose of this study is to examine and to compare gait characteristics under single- and dual-task conditions among healthy subjects together with AD patients at different stages of disease (i.e., pre-dementia, mild and moderate dementia stages).
Looking for future studies?
Notify Me60 year and older
All sexes
Observational
Angers, 49933, France
Although gait disorders are frequently associated with Alzheimer's disease (AD), few studies have focused on their characterization and mechanism. Exploring the associations of the gait characteristics - more particularly the gait variability - with the cognitive performance of AD patients on one hand, and with the morphological brain abnormalities on the other hand, could be useful to understanding the mechanisms of gait disorders in AD.
The main objective of this study is to examine and to compare gait characteristics under single- and dual-task conditions among healthy subjects together with AD patients at different stages of disease (i.e., pre-dementia, mild and moderate dementia stages).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: baseline
University Hospital, Angers
Other Gov
Maladie d'Alzheimer et Troubles Locomoteurs : Caracterisation Des Anomalies Temporelles de la Marche et Etude Des Correlats Anatomo-cognitifs
Acronym: GAIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04557592
Alzheimer Disease, Apraxias
Angers, France
View Trial DetailsNCT03020381
Alzheimer Disease, Apraxias
London, Ontario, Canada
View Trial DetailsNCT01872598
Alzheimer Disease, Brain Diseases
Varna, Bulgaria
View Trial DetailsNCT05783830
Alzheimer Disease, Brain Diseases
Uppsala, Sweden
View Trial Details